The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
Open accessAbstract
The ability of the endogenous fatty acid amide, cis‐oleamide (ODA), to bind to and activate cannabinoid CB 1 and CB 2 receptors was investigated. ODA competitively inhibited binding of the nonselective cannabinoid agonist [3 H]CP55,940 and the selective CB 1 antagonist [3 H]SR141716A to rat whole‐brain membranes with Ki values of 1.14 μM (0.52–2.53 μM, Hill slope=0.80, n=6) and 2.63 μM (0.62–11.20 μM, Hill slope=0.92, n=4), respectively. AEA inhibited [3 H]CP55,940 binding in rat whole‐brain membranes with a Ki of 428 n M (346–510 n M, Hill slope=−1.33, n=3). ODA competitively inhibited [3 H]CP55,940 binding in human CB 1 (hCB 1) cell membranes with a Ki value of 8.13 μM (4.97–13.32 μM, n=2). In human CB 2 transfected (hCB 2) HEK‐293T cell membranes, 100 μM ODA produced only a partial (42.5±7%) inhibition of [3 H]CP55,940 binding. ODA stimulated [35 S]GTP γ S binding in a concentration‐dependent manner (EC 50=1.64 μM (0.29–9.32 μM), R2=0.99, n=4–9), with maximal stimulation of 188±9% of basal at 100 μM. AEA stimulated [35 S]GTP γ S binding with an EC 50 of 10.43 μM (4.45–24.42 μM, R2=1.00, n=3, 195±4% of basal at 300 μM). Trans‐oleamide (trans‐ODA) failed to significantly stimulate [35 S]GTP γ S binding at concentrations up to 100 μM. ODA (10 μM)‐stimulated [35 S]GTP γ S binding was reversed by the selective CB 1 antagonist SR141716A (IC 50=2.11 n M (0.32–13.77 n M), R2=1.00, n=6). The anatomical distribution of ODA‐stimulated [35 S]GTP γ S binding in rat brain sections was indistinguishable from that of HU210. Increases of similar magnitude were observed due to both agonists in the striatum, cortex, hippocampus and cerebellum. ODA (10 μM) significantly inhibited forskolin‐stimulated cyclic AMP (cAMP) accumulation in mouse neuroblastoma N1E 115 cells (P=0.02, n=11). ODA‐mediated inhibition was completely reversed by 1 μM SR141716A (P<0.001, n=11) and was also reversed by pretreatment with 300 ng ml−1 pertussis toxin (P<0.001, n=6). These data demonstrate that ODA is a full cannabinoid CB 1 receptor agonist. Therefore, in addition to allosteric modulation of other receptors and possible entourage effects due to fatty acid amide hydrolase inhibition, the effects of ODA may be mediated directly via the CB 1 receptor. British Journal of Pharmacology (2004) 141, 253–262. doi:10.1038/sj.bjp.0705607
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemical characterization of a family of brain lipids that induce sleep
Cravatt, B. F., Prospero-Garcia, O., Siuzdak, G., Gilula, N. B., Henriksen, S. J., Boger, D. L., & Lerner, R. A. (1995) · Science · doi:10.1126/science.7770779 · Cited by 620 · cited 2×
“Cis-9,10-octadecanoamide (oleamide, ODA) is an endogenous sleep-inducing substance, first isolated from the cerebro-spinal fluid of sleep-deprived cats (Cravatt et al., 1995).”
Background
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…that inhibition of anandamide degradation by FAAH rather than the activation of CB1 receptors was responsible for the sleepinducing effect of oleamide (Boring et al., 1996; Mechoulam et al., 1997), but this is a matter of dispute (Fowler, 2004; Lees and Dougalis, 2004; Leggett et al., 2004).”
BackgroundThe Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Structure and function of fatty acid amide hydrolase
McKinney, M. K., & Cravatt, B. F. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133450 · Cited by 680
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Beyond THC: The New Generation of Cannabinoid Designer Drugs
Fattore, L., & Fratta, W. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00060 · Cited by 443
The Endocannabinoid System and its Modulation by Phytocannabinoids
Di Marzo, V., & Piscitelli, F. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0374-6 · Cited by 432
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 363
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350
Endocannabinoids and Their Pharmacological Actions
Pertwee, R. G. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_1 · Cited by 300
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 141
- Issue
- 2
- Pages
- 253-262
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2103297906
- Cited by
- 174
- References
- 1
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.